Ingevity Corporation (NGVT)
NYSE: NGVT
· Real-Time Price · USD
43.77
2.88 (7.04%)
At close: May 27, 2025, 3:59 PM
43.75
-0.05%
After-hours: May 27, 2025, 04:28 PM EDT
Ingevity Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Performance Materials Revenue | 609.6M | 902.1M | 1.12B | 874.7M | 510M | 490.6M | 400.4M | 698.6M | 301M |
| Performance Materials Revenue Growth | -32.42% | -19.44% | +28.02% | +71.51% | +3.95% | +22.53% | -42.69% | +132.09% | n/a |
| Performance Chemicals Revenue | 608.2M | 586M | 548.5M | 516.8M | 706.1M | 802.3M | 733.2M | 1.25B | n/a |
| Performance Chemicals Revenue Growth | +3.79% | +6.84% | +6.13% | -26.81% | -11.99% | +9.42% | -41.17% | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 346M | 364M | 398.7M | 385.5M | 345.4M | 281.4M | 171.4M | 142.5M | 138.8M |
| Asia Pacific Revenue Growth | -4.95% | -8.70% | +3.42% | +11.61% | +22.74% | +64.18% | +20.28% | +2.67% | n/a |
| China Revenue | 184.3M | 215.5M | 983.2M | 763.3M | 676.9M | 795.7M | 770.4M | 149.2M | 151.1M |
| China Revenue Growth | -14.48% | -78.08% | +28.81% | +12.76% | -14.93% | +3.28% | +416.35% | -1.26% | n/a |
| Emea Revenue | 187M | 1.07B | 44.2M | 23.1M | 18.9M | 22.2M | 21.9M | 662.9M | 597.8M |
| Emea Revenue Growth | -82.52% | +2319.68% | +91.34% | +22.22% | -14.86% | +1.37% | -96.70% | +10.89% | n/a |
| North America Revenue | 820.9M | 43.1M | n/a | n/a | n/a | n/a | n/a | 17.8M | 20.6M |
| North America Revenue Growth | +1804.64% | n/a | n/a | n/a | n/a | n/a | n/a | -13.59% | n/a |
| South America Revenue | 52.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| South America Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 736M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 43.1M | 39.4M | 38.7M | 41.4M | 37.7M | 43.4M | 40M | 51.7M | 48.6M | 55.9M | 54.2M | 48.7M | 40M | 48.3M | 43.5M | 47.5M | 40M | 41.5M | 34.9M | 34.5M | 38.5M | 40.8M | 40.7M | 42.5M | 39.1M | 35.9M | 34.5M | 35.9M | 26.5M | 27.9M | 26.2M | 26.3M | 26M | 30M | 29.7M | 28.9M | 27.6M | 26M | 28M | 32.1M | 28.2M |
| Selling, General, and Administrative Revenue Growth | +9.39% | +1.81% | -6.52% | +9.81% | -13.13% | +8.50% | -22.63% | +6.38% | -13.06% | +3.14% | +11.29% | +21.75% | -17.18% | +11.03% | -8.42% | +18.75% | -3.61% | +18.91% | +1.16% | -10.39% | -5.64% | +0.25% | -4.24% | +8.70% | +8.91% | +4.06% | -3.90% | +35.47% | -5.02% | +6.49% | -0.38% | +1.15% | -13.33% | +1.01% | +2.77% | +4.71% | +6.15% | -7.14% | -12.77% | +13.83% | n/a |
| Research and Development Revenue | 7.7M | 7.3M | 6.7M | 7.3M | 6.8M | 7.2M | 7.8M | 8M | 8.8M | 7.2M | 7.6M | 8.2M | 7.3M | 7M | 6.8M | 5.9M | 6.6M | 5.8M | 5.2M | 5.4M | 6.2M | 4.7M | 4.9M | 5M | 5.1M | 5.2M | 5.6M | 5.3M | 5M | 5.2M | 4.8M | 4.7M | 5.1M | 4.4M | 3.9M | 4.6M | 4.6M | 7M | n/a | n/a | n/a |
| Research and Development Revenue Growth | +5.48% | +8.96% | -8.22% | +7.35% | -5.56% | -7.69% | -2.50% | -9.09% | +22.22% | -5.26% | -7.32% | +12.33% | +4.29% | +2.94% | +15.25% | -10.61% | +13.79% | +11.54% | -3.70% | -12.90% | +31.91% | -4.08% | -2.00% | -1.96% | -1.92% | -7.14% | +5.66% | +6.00% | -3.85% | +8.33% | +2.13% | -7.84% | +15.91% | +12.82% | -15.22% | 0.00% | -34.29% | n/a | n/a | n/a | n/a |